Discover
TCRT
Alaunos Therapeutics, Inc.
2.16
1 x 1.85
1 x 2.52
bid
ask
-
0.10
4.42%
1 @ 04:00 PM
2.21 +0.05 (2.31%)
| Ytd | -33.13% | |
| 1y | -53.94% |
2.16
day range
2.31
1.67
52 week range
6.20
| Open | 2.27 | Prev Close | 2.26 | Low | 2.16 | High | 2.31 | Mkt Cap | 5.28M |
| Vol | 11.57K | Avg Vol | 16.04K | EPS | -2.12 | P/E | N/A | Forward P/E | -3.25 |
| Beta | -0.50 | Short Ratio | 10.12 | Inst. Own | 12.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 2.46 | 200-d Avg | 2.90 | 1yr Est | 1.75 |
| Income Statement | |||
| Operating Expenses | 1.01M | ||
| Research and Development Expense | 427.00K | ||
| Selling, General and Administrative Expense | 585.00K | ||
| Operating Income | -1.01M | ||
| Net Income | -1.01M | ||
| Net Income Common Stock | -1.01M | ||
| Net Income Common Stock (USD) | -1.01M | ||
| Consolidated Income | -1.01M | ||
| Earnings per Basic Share | -0.59 | ||
| Earnings per Basic Share (USD) | -0.59 | ||
| Earnings per Diluted Share | -0.59 | ||
| Earning Before Interest & Taxes (EBIT) | -1.01M | ||
| Earning Before Interest & Taxes (USD) | -1.01M | ||
| Weighted Average Shares | 1.95M | ||
| Weighted Average Shares Diluted | 1.95M | ||
| Balance Sheet | |||
| Cash and Equivalents | 354.00K | ||
| Cash and Equivalents (USD) | 354.00K | ||
| Current Assets | 970.00K | ||
| Property, Plant & Equipment Net | 82.00K | ||
| Total Assets | 1.88M | ||
| Current Liabilities | 595.00K | ||
| Total Liabilities | 595.00K | ||
| Accumulated Retained Earnings (Deficit) | -925.63M | ||
| Shareholders Equity | 1.29M | ||
| Shareholders Equity (USD) | 1.29M | ||
| Assets Non-Current | 913.00K | ||
| Trade and Non-Trade Payables | 400.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 8.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.03M | ||
| Net Cash Flow from Operations | -1.03M | ||
| Share Based Compensation | 141.00K | ||